Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
In this video, she discusses her session “Fecal Microbiota Transplantation in the Treatment of Clostridioides difficile,” which she will present at the virtual 2020 Advances in Inflammatory Bowel Disease...
In this 1-minute video, Millie Long, MD, from the University of North Carolina at Chapel Hill and cochair of the Advances in Inflammatory Bowel Disease 2020 virtual regional meeting, previews next AIBD...